Respiratory Disorders Drug Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Disorders Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsule
1.2.3 Suspension Agent
1.2.4 Injection
1.2.5 Gas (Powder) Mist
1.2.6 Tablets
1.2.7 Solution
1.2.8 Granules
1.2.9 Dropping Pill
1.2.10 Patch
1.2.11 Other
1.3 Market by Application
1.3.1 Global Respiratory Disorders Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clearing Away Heat And Detoxifying Drugs
1.3.3 Expectorant
1.3.4 Cold Medicine
1.3.5 Antiasthmatic
1.3.6 COPD Treatment Medicine
1.3.7 Cough Medicine
1.3.8 Respiratory Stimulant
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Disorders Drug Market Perspective (2017-2028)
2.2 Respiratory Disorders Drug Growth Trends by Region
2.2.1 Respiratory Disorders Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Respiratory Disorders Drug Historic Market Size by Region (2017-2022)
2.2.3 Respiratory Disorders Drug Forecasted Market Size by Region (2023-2028)
2.3 Respiratory Disorders Drug Market Dynamics
2.3.1 Respiratory Disorders Drug Industry Trends
2.3.2 Respiratory Disorders Drug Market Drivers
2.3.3 Respiratory Disorders Drug Market Challenges
2.3.4 Respiratory Disorders Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Disorders Drug Players by Revenue
3.1.1 Global Top Respiratory Disorders Drug Players by Revenue (2017-2022)
3.1.2 Global Respiratory Disorders Drug Revenue Market Share by Players (2017-2022)
3.2 Global Respiratory Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Disorders Drug Revenue
3.4 Global Respiratory Disorders Drug Market Concentration Ratio
3.4.1 Global Respiratory Disorders Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Disorders Drug Revenue in 2021
3.5 Respiratory Disorders Drug Key Players Head office and Area Served
3.6 Key Players Respiratory Disorders Drug Product Solution and Service
3.7 Date of Enter into Respiratory Disorders Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Disorders Drug Breakdown Data by Type
4.1 Global Respiratory Disorders Drug Historic Market Size by Type (2017-2022)
4.2 Global Respiratory Disorders Drug Forecasted Market Size by Type (2023-2028)
5 Respiratory Disorders Drug Breakdown Data by Application
5.1 Global Respiratory Disorders Drug Historic Market Size by Application (2017-2022)
5.2 Global Respiratory Disorders Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Respiratory Disorders Drug Market Size (2017-2028)
6.2 North America Respiratory Disorders Drug Market Size by Type
6.2.1 North America Respiratory Disorders Drug Market Size by Type (2017-2022)
6.2.2 North America Respiratory Disorders Drug Market Size by Type (2023-2028)
6.2.3 North America Respiratory Disorders Drug Market Share by Type (2017-2028)
6.3 North America Respiratory Disorders Drug Market Size by Application
6.3.1 North America Respiratory Disorders Drug Market Size by Application (2017-2022)
6.3.2 North America Respiratory Disorders Drug Market Size by Application (2023-2028)
6.3.3 North America Respiratory Disorders Drug Market Share by Application (2017-2028)
6.4 North America Respiratory Disorders Drug Market Size by Country
6.4.1 North America Respiratory Disorders Drug Market Size by Country (2017-2022)
6.4.2 North America Respiratory Disorders Drug Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Respiratory Disorders Drug Market Size (2017-2028)
7.2 Europe Respiratory Disorders Drug Market Size by Type
7.2.1 Europe Respiratory Disorders Drug Market Size by Type (2017-2022)
7.2.2 Europe Respiratory Disorders Drug Market Size by Type (2023-2028)
7.2.3 Europe Respiratory Disorders Drug Market Share by Type (2017-2028)
7.3 Europe Respiratory Disorders Drug Market Size by Application
7.3.1 Europe Respiratory Disorders Drug Market Size by Application (2017-2022)
7.3.2 Europe Respiratory Disorders Drug Market Size by Application (2023-2028)
7.3.3 Europe Respiratory Disorders Drug Market Share by Application (2017-2028)
7.4 Europe Respiratory Disorders Drug Market Size by Country
7.4.1 Europe Respiratory Disorders Drug Market Size by Country (2017-2022)
7.4.2 Europe Respiratory Disorders Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Disorders Drug Market Size (2017-2028)
8.2 Asia-Pacific Respiratory Disorders Drug Market Size by Type
8.2.1 Asia-Pacific Respiratory Disorders Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Respiratory Disorders Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Respiratory Disorders Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Respiratory Disorders Drug Market Size by Application
8.3.1 Asia-Pacific Respiratory Disorders Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Respiratory Disorders Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Respiratory Disorders Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Respiratory Disorders Drug Market Size by Region
8.4.1 Asia-Pacific Respiratory Disorders Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Respiratory Disorders Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Respiratory Disorders Drug Market Size (2017-2028)
9.2 Latin America Respiratory Disorders Drug Market Size by Type
9.2.1 Latin America Respiratory Disorders Drug Market Size by Type (2017-2022)
9.2.2 Latin America Respiratory Disorders Drug Market Size by Type (2023-2028)
9.2.3 Latin America Respiratory Disorders Drug Market Share by Type (2017-2028)
9.3 Latin America Respiratory Disorders Drug Market Size by Application
9.3.1 Latin America Respiratory Disorders Drug Market Size by Application (2017-2022)
9.3.2 Latin America Respiratory Disorders Drug Market Size by Application (2023-2028)
9.3.3 Latin America Respiratory Disorders Drug Market Share by Application (2017-2028)
9.4 Latin America Respiratory Disorders Drug Market Size by Country
9.4.1 Latin America Respiratory Disorders Drug Market Size by Country (2017-2022)
9.4.2 Latin America Respiratory Disorders Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Disorders Drug Market Size (2017-2028)
10.2 Middle East & Africa Respiratory Disorders Drug Market Size by Type
10.2.1 Middle East & Africa Respiratory Disorders Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Respiratory Disorders Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Respiratory Disorders Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Respiratory Disorders Drug Market Size by Application
10.3.1 Middle East & Africa Respiratory Disorders Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Respiratory Disorders Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Respiratory Disorders Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Respiratory Disorders Drug Market Size by Country
10.4.1 Middle East & Africa Respiratory Disorders Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Respiratory Disorders Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Respiratory Disorders Drug Introduction
11.1.4 AstraZeneca Revenue in Respiratory Disorders Drug Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 MSD
11.2.1 MSD Company Details
11.2.2 MSD Business Overview
11.2.3 MSD Respiratory Disorders Drug Introduction
11.2.4 MSD Revenue in Respiratory Disorders Drug Business (2017-2022)
11.2.5 MSD Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Respiratory Disorders Drug Introduction
11.3.4 Boehringer Ingelheim Revenue in Respiratory Disorders Drug Business (2017-2022)
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Biogen Business Overview
11.4.3 Biogen Respiratory Disorders Drug Introduction
11.4.4 Biogen Revenue in Respiratory Disorders Drug Business (2017-2022)
11.4.5 Biogen Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Respiratory Disorders Drug Introduction
11.5.4 Pfizer Revenue in Respiratory Disorders Drug Business (2017-2022)
11.5.5 Pfizer Recent Developments
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Respiratory Disorders Drug Introduction
11.6.4 Teva Revenue in Respiratory Disorders Drug Business (2017-2022)
11.6.5 Teva Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Respiratory Disorders Drug Introduction
11.7.4 Novartis Revenue in Respiratory Disorders Drug Business (2017-2022)
11.7.5 Novartis Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Respiratory Disorders Drug Introduction
11.8.4 Johnson & Johnson Revenue in Respiratory Disorders Drug Business (2017-2022)
11.8.5 Johnson & Johnson Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Respiratory Disorders Drug Introduction
11.9.4 Eli Lilly Revenue in Respiratory Disorders Drug Business (2017-2022)
11.9.5 Eli Lilly Recent Developments
11.10 Otsuka
11.10.1 Otsuka Company Details
11.10.2 Otsuka Business Overview
11.10.3 Otsuka Respiratory Disorders Drug Introduction
11.10.4 Otsuka Revenue in Respiratory Disorders Drug Business (2017-2022)
11.10.5 Otsuka Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Respiratory Disorders Drug Introduction
11.11.4 Merck Revenue in Respiratory Disorders Drug Business (2017-2022)
11.11.5 Merck Recent Developments
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Respiratory Disorders Drug Introduction
11.12.4 Takeda Revenue in Respiratory Disorders Drug Business (2017-2022)
11.12.5 Takeda Recent Developments
11.13 FibroGen
11.13.1 FibroGen Company Details
11.13.2 FibroGen Business Overview
11.13.3 FibroGen Respiratory Disorders Drug Introduction
11.13.4 FibroGen Revenue in Respiratory Disorders Drug Business (2017-2022)
11.13.5 FibroGen Recent Developments
11.14 Amgen
11.14.1 Amgen Company Details
11.14.2 Amgen Business Overview
11.14.3 Amgen Respiratory Disorders Drug Introduction
11.14.4 Amgen Revenue in Respiratory Disorders Drug Business (2017-2022)
11.14.5 Amgen Recent Developments
11.15 Dr. Reddy's Laboratories
11.15.1 Dr. Reddy's Laboratories Company Details
11.15.2 Dr. Reddy's Laboratories Business Overview
11.15.3 Dr. Reddy's Laboratories Respiratory Disorders Drug Introduction
11.15.4 Dr. Reddy's Laboratories Revenue in Respiratory Disorders Drug Business (2017-2022)
11.15.5 Dr. Reddy's Laboratories Recent Developments
11.16 Dainippon Sumitomo
11.16.1 Dainippon Sumitomo Company Details
11.16.2 Dainippon Sumitomo Business Overview
11.16.3 Dainippon Sumitomo Respiratory Disorders Drug Introduction
11.16.4 Dainippon Sumitomo Revenue in Respiratory Disorders Drug Business (2017-2022)
11.16.5 Dainippon Sumitomo Recent Developments
11.17 Abbott
11.17.1 Abbott Company Details
11.17.2 Abbott Business Overview
11.17.3 Abbott Respiratory Disorders Drug Introduction
11.17.4 Abbott Revenue in Respiratory Disorders Drug Business (2017-2022)
11.17.5 Abbott Recent Developments
11.18 Horizon Pharma
11.18.1 Horizon Pharma Company Details
11.18.2 Horizon Pharma Business Overview
11.18.3 Horizon Pharma Respiratory Disorders Drug Introduction
11.18.4 Horizon Pharma Revenue in Respiratory Disorders Drug Business (2017-2022)
11.18.5 Horizon Pharma Recent Developments
11.19 Zambon
11.19.1 Zambon Company Details
11.19.2 Zambon Business Overview
11.19.3 Zambon Respiratory Disorders Drug Introduction
11.19.4 Zambon Revenue in Respiratory Disorders Drug Business (2017-2022)
11.19.5 Zambon Recent Developments
11.20 Moehs
11.20.1 Moehs Company Details
11.20.2 Moehs Business Overview
11.20.3 Moehs Respiratory Disorders Drug Introduction
11.20.4 Moehs Revenue in Respiratory Disorders Drug Business (2017-2022)
11.20.5 Moehs Recent Developments
11.21 Pharmazell
11.21.1 Pharmazell Company Details
11.21.2 Pharmazell Business Overview
11.21.3 Pharmazell Respiratory Disorders Drug Introduction
11.21.4 Pharmazell Revenue in Respiratory Disorders Drug Business (2017-2022)
11.21.5 Pharmazell Recent Developments
11.22 Nippon Rika
11.22.1 Nippon Rika Company Details
11.22.2 Nippon Rika Business Overview
11.22.3 Nippon Rika Respiratory Disorders Drug Introduction
11.22.4 Nippon Rika Revenue in Respiratory Disorders Drug Business (2017-2022)
11.22.5 Nippon Rika Recent Developments
11.23 Chengyi Pharma
11.23.1 Chengyi Pharma Company Details
11.23.2 Chengyi Pharma Business Overview
11.23.3 Chengyi Pharma Respiratory Disorders Drug Introduction
11.23.4 Chengyi Pharma Revenue in Respiratory Disorders Drug Business (2017-2022)
11.23.5 Chengyi Pharma Recent Developments
11.24 Wuhan Grand Hoyo
11.24.1 Wuhan Grand Hoyo Company Details
11.24.2 Wuhan Grand Hoyo Business Overview
11.24.3 Wuhan Grand Hoyo Respiratory Disorders Drug Introduction
11.24.4 Wuhan Grand Hoyo Revenue in Respiratory Disorders Drug Business (2017-2022)
11.24.5 Wuhan Grand Hoyo Recent Developments
11.25 Manus Aktteva Biopharma
11.25.1 Manus Aktteva Biopharma Company Details
11.25.2 Manus Aktteva Biopharma Business Overview
11.25.3 Manus Aktteva Biopharma Respiratory Disorders Drug Introduction
11.25.4 Manus Aktteva Biopharma Revenue in Respiratory Disorders Drug Business (2017-2022)
11.25.5 Manus Aktteva Biopharma Recent Developments
11.26 Beijing Jiuhe Pharmaceutical
11.26.1 Beijing Jiuhe Pharmaceutical Company Details
11.26.2 Beijing Jiuhe Pharmaceutical Business Overview
11.26.3 Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Introduction
11.26.4 Beijing Jiuhe Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022)
11.26.5 Beijing Jiuhe Pharmaceutical Recent Developments
11.27 Daiichi Sankyo Pharmaceutical
11.27.1 Daiichi Sankyo Pharmaceutical Company Details
11.27.2 Daiichi Sankyo Pharmaceutical Business Overview
11.27.3 Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Introduction
11.27.4 Daiichi Sankyo Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022)
11.27.5 Daiichi Sankyo Pharmaceutical Recent Developments
11.28 Sinopharm
11.28.1 Sinopharm Company Details
11.28.2 Sinopharm Business Overview
11.28.3 Sinopharm Respiratory Disorders Drug Introduction
11.28.4 Sinopharm Revenue in Respiratory Disorders Drug Business (2017-2022)
11.28.5 Sinopharm Recent Developments
11.29 CTTQ
11.29.1 CTTQ Company Details
11.29.2 CTTQ Business Overview
11.29.3 CTTQ Respiratory Disorders Drug Introduction
11.29.4 CTTQ Revenue in Respiratory Disorders Drug Business (2017-2022)
11.29.5 CTTQ Recent Developments
11.30 Yangtze River Pharmaceutical Group
11.30.1 Yangtze River Pharmaceutical Group Company Details
11.30.2 Yangtze River Pharmaceutical Group Business Overview
11.30.3 Yangtze River Pharmaceutical Group Respiratory Disorders Drug Introduction
11.30.4 Yangtze River Pharmaceutical Group Revenue in Respiratory Disorders Drug Business (2017-2022)
11.30.5 Yangtze River Pharmaceutical Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Respiratory Disorders Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Capsule
Table 3. Key Players of Suspension Agent
Table 4. Key Players of Injection
Table 5. Key Players of Gas (Powder) Mist
Table 6. Key Players of Tablets
Table 7. Key Players of Solution
Table 8. Key Players of Granules
Table 9. Key Players of Dropping Pill
Table 10. Key Players of Patch
Table 11. Key Players of Other
Table 12. Global Respiratory Disorders Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 13. Global Respiratory Disorders Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 14. Global Respiratory Disorders Drug Market Size by Region (2017-2022) & (US$ Million)
Table 15. Global Respiratory Disorders Drug Market Share by Region (2017-2022)
Table 16. Global Respiratory Disorders Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 17. Global Respiratory Disorders Drug Market Share by Region (2023-2028)
Table 18. Respiratory Disorders Drug Market Trends
Table 19. Respiratory Disorders Drug Market Drivers
Table 20. Respiratory Disorders Drug Market Challenges
Table 21. Respiratory Disorders Drug Market Restraints
Table 22. Global Respiratory Disorders Drug Revenue by Players (2017-2022) & (US$ Million)
Table 23. Global Respiratory Disorders Drug Revenue Share by Players (2017-2022)
Table 24. Global Top Respiratory Disorders Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Disorders Drug as of 2021)
Table 25. Ranking of Global Top Respiratory Disorders Drug Companies by Revenue (US$ Million) in 2021
Table 26. Global 5 Largest Players Market Share by Respiratory Disorders Drug Revenue (CR5 and HHI) & (2017-2022)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Respiratory Disorders Drug Product Solution and Service
Table 29. Date of Enter into Respiratory Disorders Drug Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Respiratory Disorders Drug Market Size by Type (2017-2022) & (US$ Million)
Table 32. Global Respiratory Disorders Drug Revenue Market Share by Type (2017-2022)
Table 33. Global Respiratory Disorders Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 34. Global Respiratory Disorders Drug Revenue Market Share by Type (2023-2028)
Table 35. Global Respiratory Disorders Drug Market Size by Application (2017-2022) & (US$ Million)
Table 36. Global Respiratory Disorders Drug Revenue Share by Application (2017-2022)
Table 37. Global Respiratory Disorders Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 38. Global Respiratory Disorders Drug Revenue Share by Application (2023-2028)
Table 39. North America Respiratory Disorders Drug Market Size by Type (2017-2022) & (US$ Million)
Table 40. North America Respiratory Disorders Drug Market Size by Type (2023-2028) & (US$ Million)
Table 41. North America Respiratory Disorders Drug Market Size by Application (2017-2022) & (US$ Million)
Table 42. North America Respiratory Disorders Drug Market Size by Application (2023-2028) & (US$ Million)
Table 43. North America Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 44. North America Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 45. Europe Respiratory Disorders Drug Market Size by Type (2017-2022) & (US$ Million)
Table 46. Europe Respiratory Disorders Drug Market Size by Type (2023-2028) & (US$ Million)
Table 47. Europe Respiratory Disorders Drug Market Size by Application (2017-2022) & (US$ Million)
Table 48. Europe Respiratory Disorders Drug Market Size by Application (2023-2028) & (US$ Million)
Table 49. Europe Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 50. Europe Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 51. Asia Pacific Respiratory Disorders Drug Market Size by Type (2017-2022) & (US$ Million)
Table 52. Asia Pacific Respiratory Disorders Drug Market Size by Type (2023-2028) & (US$ Million)
Table 53. Asia Pacific Respiratory Disorders Drug Market Size by Application (2017-2022) & (US$ Million)
Table 54. Asia Pacific Respiratory Disorders Drug Market Size by Application (2023-2028) & (US$ Million)
Table 55. Asia Pacific Respiratory Disorders Drug Market Size by Region (2017-2022) & (US$ Million)
Table 56. Asia Pacific Respiratory Disorders Drug Market Size by Region (2023-2028) & (US$ Million)
Table 57. Latin America Respiratory Disorders Drug Market Size by Type (2017-2022) & (US$ Million)
Table 58. Latin America Respiratory Disorders Drug Market Size by Type (2023-2028) & (US$ Million)
Table 59. Latin America Respiratory Disorders Drug Market Size by Application (2017-2022) & (US$ Million)
Table 60. Latin America Respiratory Disorders Drug Market Size by Application (2023-2028) & (US$ Million)
Table 61. Latin America Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 62. Latin America Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Respiratory Disorders Drug Market Size by Type (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Respiratory Disorders Drug Market Size by Type (2023-2028) & (US$ Million)
Table 65. Middle East and Africa Respiratory Disorders Drug Market Size by Application (2017-2022) & (US$ Million)
Table 66. Middle East and Africa Respiratory Disorders Drug Market Size by Application (2023-2028) & (US$ Million)
Table 67. Middle East and Africa Respiratory Disorders Drug Market Size by Country (2017-2022) & (US$ Million)
Table 68. Middle East and Africa Respiratory Disorders Drug Market Size by Country (2023-2028) & (US$ Million)
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Respiratory Disorders Drug Product
Table 72. AstraZeneca Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 73. AstraZeneca Recent Developments
Table 74. MSD Company Details
Table 75. MSD Business Overview
Table 76. MSD Respiratory Disorders Drug Product
Table 77. MSD Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 78. MSD Recent Developments
Table 79. Boehringer Ingelheim Company Details
Table 80. Boehringer Ingelheim Business Overview
Table 81. Boehringer Ingelheim Respiratory Disorders Drug Product
Table 82. Boehringer Ingelheim Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 83. Boehringer Ingelheim Recent Developments
Table 84. Biogen Company Details
Table 85. Biogen Business Overview
Table 86. Biogen Respiratory Disorders Drug Product
Table 87. Biogen Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 88. Biogen Recent Developments
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Respiratory Disorders Drug Product
Table 92. Pfizer Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 93. Pfizer Recent Developments
Table 94. Teva Company Details
Table 95. Teva Business Overview
Table 96. Teva Respiratory Disorders Drug Product
Table 97. Teva Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 98. Teva Recent Developments
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Respiratory Disorders Drug Product
Table 102. Novartis Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 103. Novartis Recent Developments
Table 104. Johnson & Johnson Company Details
Table 105. Johnson & Johnson Business Overview
Table 106. Johnson & Johnson Respiratory Disorders Drug Product
Table 107. Johnson & Johnson Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 108. Johnson & Johnson Recent Developments
Table 109. Eli Lilly Company Details
Table 110. Eli Lilly Business Overview
Table 111. Eli Lilly Respiratory Disorders Drug Product
Table 112. Eli Lilly Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 113. Eli Lilly Recent Developments
Table 114. Otsuka Company Details
Table 115. Otsuka Business Overview
Table 116. Otsuka Respiratory Disorders Drug Product
Table 117. Otsuka Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 118. Otsuka Recent Developments
Table 119. Merck Company Details
Table 120. Merck Business Overview
Table 121. Merck Respiratory Disorders Drug Product
Table 122. Merck Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 123. Merck Recent Developments
Table 124. Takeda Company Details
Table 125. Takeda Business Overview
Table 126. Takeda Respiratory Disorders Drug Product
Table 127. Takeda Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 128. Takeda Recent Developments
Table 129. FibroGen Company Details
Table 130. FibroGen Business Overview
Table 131. FibroGen Respiratory Disorders Drug Product
Table 132. FibroGen Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 133. FibroGen Recent Developments
Table 134. Amgen Company Details
Table 135. Amgen Business Overview
Table 136. Amgen Respiratory Disorders Drug Product
Table 137. Amgen Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 138. Amgen Recent Developments
Table 139. Dr. Reddy's Laboratories Company Details
Table 140. Dr. Reddy's Laboratories Business Overview
Table 141. Dr. Reddy's Laboratories Respiratory Disorders Drug Product
Table 142. Dr. Reddy's Laboratories Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 143. Dr. Reddy's Laboratories Recent Developments
Table 144. Dainippon Sumitomo Company Details
Table 145. Dainippon Sumitomo Business Overview
Table 146. Dainippon Sumitomo Respiratory Disorders Drug Product
Table 147. Dainippon Sumitomo Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 148. Dainippon Sumitomo Recent Developments
Table 149. Abbott Company Details
Table 150. Abbott Business Overview
Table 151. Abbott Respiratory Disorders Drug Product
Table 152. Abbott Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 153. Abbott Recent Developments
Table 154. Horizon Pharma Company Details
Table 155. Horizon Pharma Business Overview
Table 156. Horizon Pharma Respiratory Disorders Drug Product
Table 157. Horizon Pharma Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 158. Horizon Pharma Recent Developments
Table 159. Zambon Company Details
Table 160. Zambon Business Overview
Table 161. Zambon Respiratory Disorders Drug Product
Table 162. Zambon Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 163. Zambon Recent Developments
Table 164. Moehs Company Details
Table 165. Moehs Business Overview
Table 166. Moehs Respiratory Disorders Drug Product
Table 167. Moehs Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 168. Moehs Recent Developments
Table 169. Pharmazell Company Details
Table 170. Pharmazell Business Overview
Table 171. Pharmazell Respiratory Disorders Drug Product
Table 172. Pharmazell Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 173. Pharmazell Recent Developments
Table 174. Nippon Rika Company Details
Table 175. Nippon Rika Business Overview
Table 176. Nippon Rika Respiratory Disorders Drug Product
Table 177. Nippon Rika Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 178. Nippon Rika Recent Developments
Table 179. Chengyi Pharma Company Details
Table 180. Chengyi Pharma Business Overview
Table 181. Chengyi Pharma Respiratory Disorders Drug Product
Table 182. Chengyi Pharma Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 183. Chengyi Pharma Recent Developments
Table 184. Wuhan Grand Hoyo Company Details
Table 185. Wuhan Grand Hoyo Business Overview
Table 186. Wuhan Grand Hoyo Respiratory Disorders Drug Product
Table 187. Wuhan Grand Hoyo Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 188. Wuhan Grand Hoyo Recent Developments
Table 189. Manus Aktteva Biopharma Company Details
Table 190. Manus Aktteva Biopharma Business Overview
Table 191. Manus Aktteva Biopharma Respiratory Disorders Drug Product
Table 192. Manus Aktteva Biopharma Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 193. Manus Aktteva Biopharma Recent Developments
Table 194. Beijing Jiuhe Pharmaceutical Company Details
Table 195. Beijing Jiuhe Pharmaceutical Business Overview
Table 196. Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Product
Table 197. Beijing Jiuhe Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 198. Beijing Jiuhe Pharmaceutical Recent Developments
Table 199. Daiichi Sankyo Pharmaceutical Company Details
Table 200. Daiichi Sankyo Pharmaceutical Business Overview
Table 201. Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Product
Table 202. Daiichi Sankyo Pharmaceutical Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 203. Daiichi Sankyo Pharmaceutical Recent Developments
Table 204. Sinopharm Company Details
Table 205. Sinopharm Business Overview
Table 206. Sinopharm Respiratory Disorders Drug Product
Table 207. Sinopharm Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 208. Sinopharm Recent Developments
Table 209. CTTQ Company Details
Table 210. CTTQ Business Overview
Table 211. CTTQ Respiratory Disorders Drug Product
Table 212. CTTQ Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 213. CTTQ Recent Developments
Table 214. Yangtze River Pharmaceutical Group Company Details
Table 215. Yangtze River Pharmaceutical Group Business Overview
Table 216. Yangtze River Pharmaceutical Group Respiratory Disorders Drug Product
Table 217. Yangtze River Pharmaceutical Group Revenue in Respiratory Disorders Drug Business (2017-2022) & (US$ Million)
Table 218. Yangtze River Pharmaceutical Group Recent Developments
Table 219. Research Programs/Design for This Report
Table 220. Key Data Information from Secondary Sources
Table 221. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Disorders Drug Market Share by Type: 2021 VS 2028
Figure 2. Capsule Features
Figure 3. Suspension Agent Features
Figure 4. Injection Features
Figure 5. Gas (Powder) Mist Features
Figure 6. Tablets Features
Figure 7. Solution Features
Figure 8. Granules Features
Figure 9. Dropping Pill Features
Figure 10. Patch Features
Figure 11. Other Features
Figure 12. Global Respiratory Disorders Drug Market Share by Application: 2021 VS 2028
Figure 13. Clearing Away Heat And Detoxifying Drugs Case Studies
Figure 14. Expectorant Case Studies
Figure 15. Cold Medicine Case Studies
Figure 16. Antiasthmatic Case Studies
Figure 17. COPD Treatment Medicine Case Studies
Figure 18. Cough Medicine Case Studies
Figure 19. Respiratory Stimulant Case Studies
Figure 20. Other Case Studies
Figure 21. Respiratory Disorders Drug Report Years Considered
Figure 22. Global Respiratory Disorders Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 23. Global Respiratory Disorders Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 24. Global Respiratory Disorders Drug Market Share by Region: 2021 VS 2028
Figure 25. Global Respiratory Disorders Drug Market Share by Players in 2021
Figure 26. Global Top Respiratory Disorders Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Disorders Drug as of 2021)
Figure 27. The Top 10 and 5 Players Market Share by Respiratory Disorders Drug Revenue in 2021
Figure 28. North America Respiratory Disorders Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 29. North America Respiratory Disorders Drug Market Size Market Share by Type (2017-2028)
Figure 30. North America Respiratory Disorders Drug Market Size Market Share by Application (2017-2028)
Figure 31. North America Respiratory Disorders Drug Market Size Share by Country (2017-2028)
Figure 32. United States Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Canada Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Europe Respiratory Disorders Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Europe Respiratory Disorders Drug Market Size Market Share by Type (2017-2028)
Figure 36. Europe Respiratory Disorders Drug Market Size Market Share by Application (2017-2028)
Figure 37. Europe Respiratory Disorders Drug Market Size Share by Country (2017-2028)
Figure 38. Germany Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. France Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. U.K. Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Italy Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Russia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Nordic Countries Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Asia-Pacific Respiratory Disorders Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Asia Pacific Respiratory Disorders Drug Market Size Market Share by Type (2017-2028)
Figure 46. Asia Pacific Respiratory Disorders Drug Market Size Market Share by Application (2017-2028)
Figure 47. Asia Pacific Respiratory Disorders Drug Market Size Share by Region (2017-2028)
Figure 48. China Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Japan Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. South Korea Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Southeast Asia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. India Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Australia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 54. Latin America Respiratory Disorders Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 55. Latin America Respiratory Disorders Drug Market Size Market Share by Type (2017-2028)
Figure 56. Latin America Respiratory Disorders Drug Market Size Market Share by Application (2017-2028)
Figure 57. Latin America Respiratory Disorders Drug Market Size Share by Country (2017-2028)
Figure 58. Mexico Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Brazil Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. Middle East & Africa Respiratory Disorders Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 61. Middle East and Africa Respiratory Disorders Drug Market Size Market Share by Type (2017-2028)
Figure 62. Middle East and Africa Respiratory Disorders Drug Market Size Market Share by Application (2017-2028)
Figure 63. Middle East and Africa Respiratory Disorders Drug Market Size Share by Country (2017-2028)
Figure 64. Turkey Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 65. Saudi Arabia Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 66. UAE Respiratory Disorders Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 67. AstraZeneca Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 68. MSD Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 69. Boehringer Ingelheim Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 70. Biogen Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 71. Pfizer Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 72. Teva Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 73. Novartis Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 74. Johnson & Johnson Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 75. Eli Lilly Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 76. Otsuka Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 77. Merck Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 78. Takeda Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 79. FibroGen Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 80. Amgen Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 81. Dr. Reddy's Laboratories Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 82. Dainippon Sumitomo Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 83. Abbott Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 84. Horizon Pharma Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 85. Zambon Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 86. Moehs Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 87. Pharmazell Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 88. Nippon Rika Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 89. Chengyi Pharma Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 90. Wuhan Grand Hoyo Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 91. Manus Aktteva Biopharma Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 92. Beijing Jiuhe Pharmaceutical Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 93. Daiichi Sankyo Pharmaceutical Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 94. Sinopharm Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 95. CTTQ Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 96. Yangtze River Pharmaceutical Group Revenue Growth Rate in Respiratory Disorders Drug Business (2017-2022)
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
Industry Market Size
